About IJO Press

Brief Introduction on IJO Press

International Journal of Ophthalmology Press (IJO Press) was founded in 2003, and approved by the State Administration of Press Publication, Radio, Film and Television of China. Now we are publishing two monthly academic periodicals: 
1 International Journal of Ophthalmology--IJO (ISSN:2222-3959)  is an ophthalmological publication in English and has been indexed in SCI-Expanded, PubMed, PubMed-Central, Chemical Abstracts, Scopus, EMBASE , IC etc. , also selected as 2015' The Highest International Impact Academic Journal of China. Its IF in JCR 2017 is 1.166.

International Eye Science—IES (ISSN:1672-5123), (Chinese Name Guoji  Yanke Zazhi) is a Chinese-English-mixed Ophthalmological publication and has been indexed in Scopus, EMBASE, CA ,IC and China Core Periodical of Science and Technology.

IJO Press is the cooperative institution of U.S. National Library of Medicine (NLM), International Council of Ophthalmology (ICO), American Academy of Ophthalmology (AAO) and Thomson Reuters. And it is also the teaching base of Xi’an Jiaotong University, Xi'an Medical University and Xinxiang Medical University. 300 square meters of office space, about 20 managerial and editorial members, advanced office facilities and independent website make IJO Press the leading level in periodicals of China, particularly in journal’s internationalization, digitization and networking. IJO Press is a growing enterprise with great potential and bright prospect. 

Major members of scientific quality team
General Scientific Advisors 
Prof. Hugh Taylor (President of International Council of Ophthalmology(ICO)); Prof.Bruce Spivey (Immediate Past President of ICO);
and Prof.Daiming Fan (Academician and Vice President, Chinese Academy of Engineering and Prof. Serge Resnikoff (WHO Senior Speciatist for Prevention of blindness).

International Scientific Advisors 

Prof. Chi-Chao Chan (National Eye Institute, USA) and Prof. Richard L Abbott (Ex-President of AAO/PAAO) et al.
Honorary Editors-in-Chief
Prof. Mark Tso (Ex-vice President of ICO), Prof. Li-Xin Xie(Academician of Chinese Academy of Engineering/Honorary President of Chinese Ophthalmological Society);
Prof. Dennis Lam (President of APAO) 

Chief Editor Prof. Xiu-Wen Hu (President of IJO Press).

Prof. Yan-Nian Hui (Ex-Director, Eye Institute of the Whole Army, the Fourth Military Medical University of Chinese PLA) and
Prof. George Chiou (Founding chief editor of Journal of Ocular Pharmacology & Therapeutics).

Associate Editors-in-Chief 
Prof. Ning-Li Wang (President of Chinese Ophthalmological Society); Prof. Ke Yao (President Elect of Chinese Ophthalmological Society) and
Prof.William Smiddy (Bascom Palmer Eye institute) et al.

Major members of the management team
President /Chief Editor   Prof. Xiu-Wen Hu (Owners of IJO Press, Xi’an China).
 Prof. Yan-Nian Hui (Ex-Director, Eye Institute of the Whole Army,the Fourth Military Medical University of Chinese PLA, Xi’an China)
Associate Editor-in Chief
   Prof.Yu-Sheng Wang (Director, Eye Institute of the Whole Army,the Fourth Military Medical University of Chinese PLA, Xi’an China)
Managing Director MS. Xinyue Hu (IJO Press, Xi’an China)
Editorial Director MS. Juan Peng ( Editorial office, Xi’an China)


Publication credentials:
Prof. Xiu-Wen Hu, President/Chief Editor is the founder of two academic publications, International Journal of Ophthalmology (IJO) and International Eye Science(IES-Guoji Yanke Zazhi), with rich experience in scholarly and life science publishing.  IJO has been indexed in SCI-Expanded, PubMed, PubMed-Central, Chemical Abstracts, Scopus, EMBASE , and selected as 2015' The Highest International Impact Academic Journal of China. Its IF in JCR 2015 is 0.939. IES (Guoji  Yanke Zazhi) is a Chinese-English-mixed Ophthalmological publication and has been indexed in Scopus, EMBASE, CA and China Core Periodical of Science and Technology.

Prof. Yan-Nian Hui, Editor-in-Chief of IJO and IES is the Chief Editor of the national selection teaching material “Ophthalmology”, and the Associate Editors-in-Chief of the Medical Encyclopedia of China; He is also the ex Associate Editor-in-Chief of Chinese Journal of Ophthalmology(indexed in Medline),and published more than 200 papers and 12 Monographs with extensive experience in scholarly and life science publishing.

Editorial Policy

 Peer Review
 All manuscripts are subjected to double blind peer-review and editorial approval before accepting for publication.All contributions will be sent to at least three or more independent reviewers, selected by the editors. Authors are welcome to suggest suitable independent reviewers and may also request that the journal excludes one or two individuals or laboratories, but the editor's decision on the choice of referees is final. Editors, authors and reviewers are required to keep confidential all details of the editorial and peer review process on submitted manuscripts, the peer review process is confidential and conducted anonymously; Outcomes of the review process include acceptance, acceptance with revisions but without re-review, revise and resubmit, or rejection. Results of the review process are normally available in 3months of submission.

Ethical Approval of Studies and Informed Consent
For all manuscripts reporting data from studies involving human participants or animals, a formal review and approval, or formal review and waiver by an appropriate institutional review board or ethics committee is required, and should be described in the Subjects and Methods section. For investigators who do not have a formal ethics review committee (institutional or regional), the principles outlined in the Declaration of Helsinki (2008) must be followed. For investigations done in humans, the Methods section must state the manner in which informed consent was obtained from the subjects (i.e. oral, or written), and whether participants received a stipend. If experimental animals were used in the research, IJO Press requires that authors confirm adherence to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research in the Methods section of their manuscript.

Conflicts of Interest
A conflict of interest may exist when an author (or the author's institution or employer) has financial, or personal relationships that could inappropriately influence (or bias) the author's decisions, work, or manuscript. All authors are required to disclose potential conflicts of interest in the Acknowledgments section of the manuscript by following the Recommendations of the International Committee of Medical Journal Editors (ICMJE) http://www.icmje.org/urm_main.html  Authors without conflicts of interest, including relevant financial interests, activities, relationships, and affiliations, should indicate that no conflicts of interest exist in the Acknowledgments section of their manuscript. e.g.
Conflicts of Interest: Wang H, None; Barteselli G, None; Freeman WR, None; Lee SN, None; Chhablani J, None; El-Emam S, None; Cheng L, None. Foundations: All financial support for the research and the work should be clearly and completely identified in an Acknowledgment section of the manuscript. Clinical Trials: When publishing clinical studies, IJO Press aims to comply with the Recommendations of International Committee of Medical Journal Editors (ICMJE) on trials registration. Therefore, authors are requested to register the clinical trial presented in the manuscript in a public trials registry, and include the trial registration number at the end of the abstract. The following sites are recognized primary registries by the World Health Organization and the ICMJE.
http://ncrc.cdc.go.kr (Republic of Korea)
IJO Press uses Crossref Similarity Check (powered by iThenticate) and AMLC powered by CNKI to screen submitted contents, and we will do some investigation if the software raises any concerns. If plagiarism is detected after manuscript is submitted, the manuscript will be rejected; If plagiarism is detected after publication, we may issue a correction or retraction notice for the related paper. We reserve the right to inform authors' institutions about plagiarism detected either before or after publication. Articles containing plagiarism will be removed from publication and will be reported to the proper authorities.

Publication Policy
According to the IJO Press publication Policy, only the Publication fees are billed per article upon acceptance in order to offset processing charges of articles; the paper reaching the world advanced level will acquire the priority with free publication on IJO and IES. All of the articles are free to access immediately on IJO Press website from the date of publication. Accepted papers may not be reproduced by any commercial use, in whole or in part, without the written consent of the publisher.

Content License
IJO Press applies the  Creative Commons Attribution (CC BY NC ND) license to works we publish. This license was developed to facilitate open access.
Citation Example:
Citation: Sanctis Ud,Alovisi C,Bauchiero L,Caramello G,Girotto G,Panico C,Vinai L,Genzano F,Amoroso A,Grignolo F.Changing trends in corneal graft surgery: a ten-year review.Int J Ophthalmol 2016;9(1):48-52,doi:10.18240/ijo.2016.01.08

Advertising policies
Advertising on web or print journal is the fastest growing medium for product promotion If you would like to publicize some new research in progress or conference (workshop) information etc. a publicity service will be available for your information, for more details please send email to ijoress@163.com  

Contact us
 Press of International Journal of Ophthalmology (IJO Press)

 Room 11707-08,Building 2, Unit 1 ,Wanda Plaza, No.8 Yanta North Road, Xi'an 710054, Shaanxi Province P.R.China

 Tel: (+8629)82210956 Fax: (+8629)82245172

Email: ijopress@163.com   ijo2000@126.com  

Website: http://ies.ijo.cn  (Chinese) www.ijo.cn  (English)